Sign in

NCT06718855Completed

Cognitive Functioning in People With Myasthenia Graivs: Impact on Daily Life Activities, Work, Disability and Quality of Life

Source: ClinicalTrials.gov · Last updated 19 Feb 2026

Brief summary (registry, in English)

MYCOG primarily aims to estimate the prevalence of cognitive difficulties in patients with MG treated at Besta Institute. Secondary aims include: a) assess the degree to which cognitive difficulties are associated to work impairment, limitations in ADL, symptoms of anxiety and depression, fatigue, disability and QoL; b) assess whether patients with different MG types show different degrees of cognitive impairment; c) assess whether patients with different MG antibody profiles show different degrees of cognitive impairment; d) assess whether patients under different MG-specific pharmacological treatments show different degrees of cognitive impairment.

Status (registry)
Completed
Study type
Observational
Enrollment
150 (actual)
First submitted
2 Dec 2024
Start date
7 Jun 2023
Primary completion date
12 Aug 2025
Lead sponsor
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
NCT number
NCT06718855

What you commit to

  • Study type: Observational
  • Participants enrolled: 150
  • From 7 Jun 2023 to the primary completion date, 12 Aug 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • psychiatric comorbidies of psychotic nature;
  • respiratory impairment (patients under mechanical ventilation)

Age

  • patients who live in a nursing home for aged or disabled persons;

Other

  • do not accept to participate on a voluntary basis;
  • patients who should be excluded based on physician's judgement;

Who the study is looking for

  • Patients with MG,
  • followed-up at Besta institute
  • aged 18-99,
  • able to understand Italian language;

Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Fondazione IRCCS Istituto Neurologico Carlo Besta
Coordinator of this site? Confirm its status
MilanItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.